Furusawa, T.* et al. Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer. Mol. Carcinog. 63, 1024-1037 (2024)
Feng, Y.* et al. Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol. Carcinog. 57, 216-224 (2018)
Yin, J.* et al. Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol. Carcinog. 56, 1663-1672 (2017)
Zhou, F.S.* et al. Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk - a re-analysis of eight GWASs. Mol. Carcinog. 56, 1227-1238 (2017)
Ahlemann, M.* et al. Carcinoma-associated elF3i overexpression facilitates mTOR-dependent growth transformation. Mol. Carcinog. 45, 957-967 (2006)
Hergenhahn, M.* et al. The Chemopreventive Compound Curcumin is an Efficient Inhibitor of Epstein-Barr Virus BZLF1  Transcription in Raji DR-LUC Cells. Mol. Carcinog. 33, 137-145 (2002)